These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3878608

  • 1. Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies.
    Hornsey V, Micklem LR, McCann MC, James K, Dawes J, McClelland DB, Prowse CV.
    Thromb Haemost; 1985 Aug 30; 54(2):510-4. PubMed ID: 3878608
    [Abstract] [Full Text] [Related]

  • 2. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D.
    Thromb Haemost; 1990 Oct 22; 64(2):326-32. PubMed ID: 1702906
    [Abstract] [Full Text] [Related]

  • 3. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
    Moake JL, Olson JD, Troll JH, Weinger RS, Peterson DM, Cimo PL.
    J Lab Clin Med; 1980 Jul 22; 96(1):168-84. PubMed ID: 6967100
    [Abstract] [Full Text] [Related]

  • 4. Characterisation of a monoclonal antibody to von Willebrand factor as a potent inhibitor of ristocetin-mediated platelet interaction and platelet adhesion.
    Jorieux S, de Romeuf C, Samor B, Goudemand M, Mazurier C.
    Thromb Haemost; 1987 Jun 03; 57(3):278-82. PubMed ID: 3116700
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB, Puszkin EG, Sussman II, Mauss EA.
    J Lab Clin Med; 1990 Sep 03; 116(3):305-14. PubMed ID: 2401846
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Platelet-binding of the von Willebrand factor.
    Green D, Muller HP.
    Thromb Haemost; 1978 Jun 30; 39(3):689-94. PubMed ID: 309191
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S, Yamamoto H, Nagano M, Arisaka H, Kayahara T, Yoshimoto R.
    Br J Pharmacol; 1997 Sep 30; 122(1):165-71. PubMed ID: 9298543
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.